Recent Headlines
AnaSpec’s Published References Passes 500
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 500. - August 26, 2007 - AnaSpec, EGT Group
New Help for Smokers Trying to Quit
Paradise Promotions Ltd., a Canadian corporation that manufactures and distributes a government approved herbal-based, smoking cessation aid across Canada, is preparing to launch the medicine into the United States marketplace. - August 25, 2007 - Paradise Promotions Ltd.
AnaSpec Introduces 10 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added ten (10) new antibodies to its growing collection of catalog antibodies. Anti-MAP1-LC3 beta (NT) - Cat# 29783, 50 µg Host:rabbit polyclonal; Species... - August 25, 2007 - AnaSpec, EGT Group
AnaSpec Introduces CEF Control Peptide Pool
One of the world’s largest providers of catalog peptides, AnaSpec introduced its CEF Control Peptide Pool. Previously available only individually, this group of peptides is now available pooled. The CEF Control Peptide Pool is a group of 32 peptides, 8-12 amino acids in length, with... - August 23, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 28 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twenty-eight (28) new antibodies to its growing collection of catalog antibodies. - August 22, 2007 - AnaSpec, EGT Group
Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve on Chemotherapy
Samaritan announced that it has entered into an exclusive licensing agreement with Georgetown University for a patent covering the Peripheral Benzodiazepine Receptor (PBR) which has led to Cancer drug candidates with the ability to inhibit cancerous tumors; and an imaging technique that could possibly distinguish cancerous tumors for a more targeted and improved chemotherapy. - August 21, 2007 - Samaritan Pharmaceuticals
AnaSpec Introduces New 2007-2009 Combinatorial Chemistry Catalog
One of the world’s largest providers of unusual amino acids, today AnaSpec announced the release of its 2007-2009 Combinatorial Chemistry catalog. - August 18, 2007 - AnaSpec, EGT Group
Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in Pipeline
Samaritan Pharmaceuticals has exclusively licensed a patent application entitled "Structure Based Drug Design of Steroid Inhibitors" from Georgetown University. - August 16, 2007 - Samaritan Pharmaceuticals
To Gift or Not to Gift: Poll Results Reveal Surprising Insight on the Best Gifts for Men
Buying gifts for men can be a tricky situation. While most men prefer gifts they can actually use, the traditional stand-bys (such as clothing, hardware and gadgets) sometimes leave much to be desired. Other gift options recently gaining attention are skincare and grooming products. Modern trends... - August 15, 2007 - MenScience Androceuticals
Aerotrim Wins £3.9M Order from UK MoD
Aerotrim (Warminster) Ltd has secured a £3.9M order for manufacturing insulation lining for MoD tentage used in field operations. - August 04, 2007 - Aerotrim Group
Analytical Results Highlight Efficacy of AnaSpec MOG Peptides
Reporting on results gathered from its antibody and assay kit departments, AnaSpec has released data that supports the efficacy of its MOG(35-55) peptide. Analytical results reported the following: AnaSpec’s mouse/rat MOG(35-55) peptide induced EAE in C57BL/6 mice with 100% incident (10/10). - July 28, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Acetylated and Methylated Lysines
AnaSpec has introduced acetylated, mono-methylated, di-methylated and tri-methylated Lysine for the synthesis of histone peptides. The use of these building blocks, although not limited to making synthetic histone peptides, provides additional tools for researchers to help unravel the... - July 28, 2007 - AnaSpec, EGT Group
Travel Kit Sends Men's Grooming Woes Packing
330 million Americans are expected to travel this summer (according to the Travel Industry Association), with men making up a large part of that number. And whether they are businessmen or vacationers, a common trend is for men to cram all grooming items into one inefficient package, often taking... - July 27, 2007 - MenScience Androceuticals
AnaSpec Introduces Fourteen New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fourteen (14) new peptides for drug discovery research. HIV Nef (68–76) - Cat# 61673 This HIV nef peptide 68 to 76 amino acids was identified in HIV-infected individuals. It is a B7... - July 27, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 12 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twelve (12) new antibodies to its growing collection of catalog antibodies. The targeted research area for these antibodies is signal transduction and matrix... - July 26, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Ten New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new peptides for drug discovery research. MUC4 - Cat# 61339 This peptide is derived from the tandem repeat of Muc 4 mucin protein. Mucins are highly O-glycosylated proteins which... - July 25, 2007 - AnaSpec, EGT Group
Xcelience Expanding Operations
The Tampa-based contract research organization acquires a brand new building. - July 23, 2007 - Xcelience, LLC
AnaSpec Introduces Eleven New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eleven (11) new peptides for drug discovery research. - July 22, 2007 - AnaSpec, EGT Group
Supplement Marketer Signs Agreement with Amazon.com, Inc.
Parason Health Products, Inc., makers of ISNA Halal certified dietary supplements, signs agreement with Fortune 500 online e-commerce retailer Amazon.com to sell Parason® brand products. - July 20, 2007 - Parason Health Products, Inc.
AnaSpec Introduces New Selection of Cathelicidin Peptides
Cathelicidins are cationic peptides that have broad-range antimicrobial activity. These peptides belong to the family of anti-microbial peptides which form part of the host’s important innate immunity mechanism. - July 20, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Anti-MMP-1 & Anti-MMP-13 (Hinge) Antibodies
AnaSpec has introduced its newest antibody solutions – anti-MMP-1 (Hinge) and anti-MMP-13 (Hinge) antibodies. Strategically raised against the hinge regions of MMP-1 and MMP-13, the epitopes do not overlap the catalytic domain and will not influence the activity of the MMP ferment in... - July 19, 2007 - AnaSpec, EGT Group
CureHIV Predicts Number of HIV Cases to Skyrocket
Dr. Hershline states that, baring a new preventative, CureHIV now predicts over 700 million worldwide HIV infected humans by the New Year 2018, as this global pandemic emerges. - July 15, 2007 - CureHIV
American Peptide Symposium Poster Describes Synthesis of Hydrocarbon-Stapled Peptides
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a technical poster that described the facile synthesis of a hydrocarbon-stapled peptide. Asymmetric synthesis of (S)-Fmoc-α-(2’-pentenyl)-alanine was successfully accomplished via an Ala-Ni (II)-BPB-complex... - July 14, 2007 - AnaSpec, EGT Group
AnaSpec Presents Late-Breaking In Vivo Imaging Poster at American Peptide Symposium
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a “late-breaking” technical poster that described in vivo imaging using a tissue-specific near infrared fluorescent peptide conjugate. Extracellular matrix proteins that contain the Arg-Gly-Asp (RGD)... - July 13, 2007 - AnaSpec, EGT Group
Cornerstone BioPharma, Inc. and SJ Pharmaceuticals, LLC Sign Co-Promotion Agreement
Cornerstone BioPharma™, the Triangle-based specialty pharmaceutical company currently focused on the development and commercialization of niche prescription medications in the respiratory arena, today announced it has signed a co-promotion agreement with SJ Pharmaceuticals (SJP). This... - July 12, 2007 - Cornerstone BioPharma
Second Annual “XanGo Cup” to Feature Pioneer Holiday RSL Friendlies with Elite Clubs Everton and Boca Juniors
Events Include Official Opening of RSL’s New XanGo Campus Practice Field - June 29, 2007 - XanGo, LLC
PharmaChem Publishes AnaSpec Article on Peptides as Antigens
The June issue of PharmaChem, an Italian journal covering the drug discovery industry, featured an article written by AnaSpec called “Peptides as Antigens.” The technical article, written by Dr. Daniel Li and Cecilia Po, outlines the advantages and methodologies behind using peptides as... - June 24, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte™ Beta-Secretase Assay Kit
Leveraging one of the world’s largest collections of amyloid peptides, AnaSpec has introduced its latest development in novel solutions for amyloid-related research - the new SensoLyte™ 520 Beta-Secretase Assay Kit. Beta-secretase catalyzes a key step in the production of beta-amyloid... - June 22, 2007 - AnaSpec, EGT Group
MenScience Acne Spot Repair Gives New Meaning to "In Your Face"
For the majority of men, acne flare-ups do not end with the teen years. Whether it’s a lone pimple or a full-on breakout, acne is an irritating condition that plagues men throughout their lives. It’s because of this that MenScience has created a product that targets pimples and... - June 20, 2007 - MenScience Androceuticals
AnaSpec Introduces Industry’s First and Only Anti-MOG ELISA Kits
Drawing on its broad portfolio of MOG (35-55) and other multiple sclerosis (MS) experimental autoimmune encephalomyelitis (EAE)-related peptides, AnaSpec has just released its new line of SensoLyte™ Anti - MOG ELISA Kits - the industry’s first and only anti-MOG ELISA kits. Myelin... - June 16, 2007 - AnaSpec, EGT Group
Metamize365 Introduced – Set to Combat the Over-Looked Issue of Metabolic Syndrome
Dr. Steven Lamm announced yesterday the introduction of his new dietary supplement, Metamize 365. The product is aimed to help combat the often-overlooked metabolic syndrome problem in the US. "Over 50% of Americans have a problem with their metabolism. This often leads to diabetes, heart... - June 13, 2007 - Metamize 365
AnaSpec Prepares Technical Poster about Beta-Secretase Assay for Experimental Biology 2007
At the 2007 Experimental Biology conference in Washington, DC, AnaSpec prepared a technical poster entitled, "A Sensitive Fluorimetric Assay for Detection of beta-Secretase Activity Using a Novel FRET Peptide Substrate." The poster documented the following findings: • A highly... - June 08, 2007 - AnaSpec, EGT Group
Summer Fun for Dad and Son This Father’s Day, Give a Dad a Gift That Shines
June ushers in Father’s Day and Sun Safety Week, so in honor of both, MenScience is awarding a ‘Dad that Shines the Brightest Award’. The winner will receive the entire MenScience Father’s Day sun care gift set, complete with the TiO2 Sunblock SPF 30, Advanced Lip... - June 01, 2007 - MenScience Androceuticals
Novel Agent for Reactive Metabolite Detection
Bioactivation of drug candidates resulting in chemically reactive, electrophilic metabolites have always presented a major challenge to pharmaceutical companies. Moreover, the measurement of these metabolites has been hampered by the lack of an effective quantitative method. QA-GSH is a novel new... - May 31, 2007 - AnaSpec, EGT Group
Xcelience Will Acquire New Technologies to Enhance Drug Development Processes
The Tampa-based Contract Research Organization signed a partnership that will form new opportunities in the pharmaceutical industry. - May 24, 2007 - Xcelience, LLC
Zoft Gum Company Launches New Product to Ease the Pain of Menopause
Zoft Menopause Gum offers relief for menopausal symptoms in a convenient chewing gum product. - May 23, 2007 - Zoft Gum Company
AnaSpec Introduces Line of Insulin Receptor Antibodies
The insulin receptor is a transmembrane receptor that belongs to the tyrosine kinase receptors class. It is a heterotetrameric glycoprotein composed of disulfide-linked subunits in a β-α-α-β configuration. This transmembrane receptor consists of 95kDa β-subunit, a single... - May 23, 2007 - AnaSpec, EGT Group
Industry’s First West Nile Virus Protease Assay Kits
While West Nile virus (WNV) has had significant outbreaks throughout the world since it was first identified, commercially available assay kits for the detection of WNV protease inhibitors had not been developed until now. With the SensoLyte™ series of WNV Protease Assay Kits AnaSpec, a... - May 17, 2007 - AnaSpec, EGT Group
Age Defying Collagen Capsule Made in NZ
Puraz Health’s product - 100% Collagen, contains pure collagen and is manufactured in New Zealand. The unique design of the capsules means that collagen can be distributed to where it may have depleted: to joints, ligaments and to the biggest organ, the skin. This means that collagen, in the past only available to plastic surgeons, is now available to the whole body in natural capsule form. - May 08, 2007 - Puraz Health
New Research Presented by MD Anderson and University of Utah Verifies Dry Connections with PhaSeal
New evidence-based research was presented at ONS Congress by MD Anderson and the University of Utah which concluded only the PhaSeal System confined the drug, thus proving the prevention of drug exposure from preparation through administration of hazardous drugs. - May 05, 2007 - Carmel Pharma
Carmel Pharma, Inc. Launches New PhaSeal Preparation Component
Carmel Pharma, Inc. launches their new Protector 28 (P28). This preparation component is the latest advancement of the PhaSeal System and is available now. - May 03, 2007 - Carmel Pharma
Personalized Lab Services, LLC Offers New, Next-Day HIV-1 Test with +99.9% Proven Accuracy
Personalized Lab Services, LLC that distributes the only U.S. Food and Drug Administration (FDA)-approved at-home HIV-1 test, announced today that it has begun providing next business day results for its Express HIV-1 Test System. The accelerated, next business-day results continue to provide the... - April 28, 2007 - Personalized Lab Services, LLC
MenScience Tackles Men's Heart Health with the Omega 3 Supplement Formula
Because of the many benefits displayed by Omega-3 in its role in men’s cardiovascular health, MenScience has created the Omega 3 Supplement Formula. Its pharmaceutical-grade formula incorporates a high dose (1500 mg) of Omega-3 fatty acids to help protect men’s cardiovascular health, promote healthy brain function and mood levels, and increase joint and muscle mobility. - April 26, 2007 - MenScience Androceuticals
Carmel Pharma Offers New Continuing Education Program
Carmel Pharma, manufacturers and distributors of PhaSeal, announced today that they are now offering an accredited continuing education (CE) program developed by STAT Educational Services, an accredited provider of continuing education for various healthcare professionals. - April 25, 2007 - Carmel Pharma
New Medical Breakthrough: FDA Approved Device Can Turn Deadly Oral Cancer Into Treatable Cancer
A new breakthrough technology sets new oral tissue screening standards, enabling cancerous lesions to be diagnosed that may be undetectable under regular overhead white dental lights. The new device, VELscope, uses blue excitation light and a specialized filter to help dental professionals screen... - April 24, 2007 - Dentistry For Health New York, PLLC
Interleukin & Chemokine Antibodies – Two Types of Cytokine Antibodies
Interleukin-32 (IL-32), whose expression is increased following activation by IL-2, was initially identified as a transcript (NK4) selectively expressed in lymphocytes and NK cells.1 - April 18, 2007 - AnaSpec, EGT Group
ABRF Poster Presents Comparison of Fluorescent Peptide Synthesis Methods
At the 2007 annual conference of the Association of Biomolecular Resource Facilities, AnaSpec presented a technical poster that compared the synthesis of a fluorescent peptide using two types of resins. The results of the poster indicated that the use of an unprotected resin was just as effective... - April 13, 2007 - AnaSpec, EGT Group
New Dye Solution for Far Red to NIR Imaging
Utilizing its proprietary HiLyte Fluor™ technology, AnaSpec has introduced dye solutions for far red to NIR imaging. AnaSpec’s HiLyte Fluor™ 647, HiLyte Fluor™ 680, and HiLyte Fluor™ 750 provide AnaSpec with a range of dyes that cover the spectrum. AnaSpec has also... - April 11, 2007 - AnaSpec, EGT Group
New Instant On-the-Spot Employee Drug Test
99.9% Accurate, FDA Cleared, Simple Mouth and Gum Swab Test - April 05, 2007 - Personalized Lab Services, LLC
New Evidence-based Research will be Unveiled During 'Ask the Experts’ at ONS Congress in April
New evidence-based research for determining adherence to the NIOSH definition of a closed-system will be unveiled during ‘Ask the Experts’ at the ONS Congress on Wednesday, April 25 in Las Vegas, NV. ‘Ask the Experts’ will be held from 1pm-2pm on Wednesday, April 25 in the... - April 04, 2007 - Carmel Pharma